Status:
COMPLETED
Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
United States Department of Defense
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Anorexia Nervosa
Eligibility:
FEMALE
15-30 years
Phase:
PHASE2
PHASE3
Brief Summary
This study seeks to gain new information on why young women with anorexia nervosa are predisposed to early bone loss and osteoporosis. Through a randomized treatment trial in which participants will r...
Detailed Description
Profound osteopenia is a frequent and often irreversible complication of anorexia nervosa (AN). Adolescents with AN often have a reduced peak bone mass and are at increased risk for early osteoporosis...
Eligibility Criteria
Inclusion
- Age 15 - 30 years
- Anorexia nervosa by psychiatric criteria
- Amenorrhea for at least 3 months
Exclusion
- Receiving no medications known to affects bone metabolism
- No other chronic medical conditions
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00310791
Start Date
April 1 2004
End Date
December 1 2010
Last Update
April 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Boston
Boston, Massachusetts, United States, 02115